Bristol, Roche, Wyeth Injectables Cited In FDA GMP Warning Letters
Executive Summary
Bristol-Myers Squibb, Roche and American Home Products have been cited for good manufacturing practices violations at their injectable and suspension products facilities in recent FDA warning letters.